MEDGENOME

A decade ago, the team at MedGenome embarked on a mission to democratize genomics and make it accessible to all. While affordability was one of the initial challenges for the adoption of genomics solutions in emerging countries, MedGenome has played a key role in reducing costs, educating the stakeholders and making these advancements more widely available. Dr. Amit Kakar MD, Chairman of the MedGenome Board and Managing Partner and Head of Asia Novo Holdings speaks with Sushmita Panda of FE Healthcare about MedGenome's future, which is focused on advancing integrated diagnostics and driving continuous innovation, especially by incorporating AI and machine learning. The goal is to make these cutting-edge technologies more accessible across the country and thus improve patient care. #MedGenome #Genetics #Genomics #GenomicSolutions #GenomicsRevolution #Innovation #PatientCare

We are thrilled to announce that MedGenome has been honored with the 2024 ASK Private Wealth HURUN INDIA Future Unicorn Award for Innovation in Genomics at the prestigious India Future Unicorn Awards, held on November 20, 2024, in Bengaluru. Our CFO, SURAJIT CHAKRABARTTY, had the privilege of accepting this award on behalf of the team at MedGenome. This recognition fuels our determination to continue pushing boundaries in the field of genomics and work tirelessly to fulfil our vision of making innovative genomic solutions affordable and accessible across the world. #MedGenome #Genetics #Innovation #InnovationInGenomics #IndiaFutureUnicornAwards

Around one-third of adults worldwide are regularly exposed to second-hand smoke which is just as dangerous as first-hand smoking and can cause Lung Cancer.   Create a smoke-free environment. Protect your loved ones. To know more about Genetic tests for lung cancer patients, please write to us at diagnostics@medgenome.com or call us at 1800 296 9696. #StopSmoking #MedGenome #Genetics #LungCancerAwareness #LungCancerPrevention #CancerPrevention #EarlyDetection #FightCancer

We are thrilled to present the third edition of our LinkedIn newsletter! At MedGenome, our unwavering commitment to bringing affordable genomic solutions more accessible is at the heart of everything we do. In line with this vision, our dedicated team has expanded our portfolio with new, cutting-edge tests, providing clinicians with even more powerful tools to improve the lives of the patients. This edition offers a deep dive into our scientific focus showcasing our research published in renowned journals, along with testimonials from clinicians who have experienced the benefits of our tests in shaping the diagnosis and treatment regime for their patients. We also share compelling case studies that highlight how our genetic tests have transformed the patient journey through early intervention. Additionally, we share how our work has been recognized in the media, both in India and globally. Don’t miss our special 10-year journey video, offering an exclusive look at the evolution of MedGenome, how we have grown over the past decade, and the driving force behind our mission. Stay connected with us and subscribe to receive the latest updates on cutting-edge advancements in genomics through #GenomeVerse. #MedGenome #Newsletter #GeneticTesting #Genetics #Genomics

Sepsis demands timely and accurate diagnosis to save lives, but antimicrobial resistance often complicates care. The Sepsis-AMR Panel by MedGenome equips clinicians with the precision needed to navigate these challenges. With a comprehensive detection panel, rapid turnaround, and CE-IVD-certified accuracy, it’s a step forward in delivering better outcomes for sepsis patients. Let’s make every moment count in critical care. For more information, reach out to us at diagnostics@medgenome.com or 1800 296 9696 #SepsisCare #AntimicrobialResistance #PrecisionDiagnostics